highlights from the ACR Convergence 2024, including groundbreaking research on SLE and lupus nephritis management, new clinical trial strategies, mechanisms

of disease and patient reported outcomes. Tune in for insights from Prof David Isenberg on pivotal studies and expert discussions that shape the future of lupus care.

patients with lupus. Lupus Academy does not make any recommendations about using a medicine outside the terms of its approved licence for use.